This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,941.81 delivery order contract is for the supply of REXULTI 2 MG TABLET 30S, a medication used to treat mental health conditions. The contract has a firm fixed price pricing type and an ultimate completion date of December 12, 2024.
This award is associated with AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor, and the company's extensive pharmaceutical distribution capabilities and experience serving federal healthcare programs make it a critical vendor for DLA and other government agencies.
Generated 3/12/25, 9:43 AM